Nodal Peripheral T-Cell Lymphoma with TFH Phenotype

Nodal Peripheral T-Cell Lymphoma with TFH Phenotype — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 33%
Top sponsor: Alliance for Clinical Trials in Oncology
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04795869	Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma	withdrawn	Phase 2	0	Northwestern UniversityOTHER	1	Oct 10, 2023	clinicaltrials

Data updated 22 days agoSource updated Oct 10, 2023source: clinicaltrials